Search research articles
Contact Us
Filters
Showing results (791-800 of 982) with videos related to
Page
of 99
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
December 6, 2008
[Guideline 'Treatment of breast cancer 2008' (revision)]
H Struikmans, J W R Nortier, E J Th Rutgers, et al.
Breast Cancer Research and Treatment
|
September 12, 2015
Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer
G Vugts, A J G Maaskant-Braat, A C Voogd, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
February 16, 2023
Persistent morbidity in Clade IIb mpox patients: interim results of a long-term follow-up study, Belgium, June to November 2022
Nicole Berens-Riha, Stefanie Bracke, Jojanneke Rutgers, et al.
Breast Cancer Research and Treatment
|
September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial
G Viale, F A de Snoo, L Slaets, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
November 20, 2015
Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study
A Kuijer, A C M van Bommel, C A Drukker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 2, 2012
Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy
Annemarie C Schmitz, Kenneth E Pengel, Claudette E Loo, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
Kim M van Pul, Ronald J C L M Vuylsteke, Rieneke van de Ven, et al.
Breast Cancer Research and Treatment
|
December 13, 2017
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 11, 2018
Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2024
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature
Sena Alaeikhanehshir, Taiwo Ajayi, Frederieke H Duijnhoven, et al.
Page
of 99
Search research articles
Search
Showing results (791-800 of 982) with videos related to
Sort By:
Page
of 99
Nederlands Tijdschrift Voor Geneeskunde
|
December 6, 2008
[Guideline 'Treatment of breast cancer 2008' (revision)]
H Struikmans, J W R Nortier, E J Th Rutgers, et al.
Breast Cancer Research and Treatment
|
September 12, 2015
Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer
G Vugts, A J G Maaskant-Braat, A C Voogd, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
February 16, 2023
Persistent morbidity in Clade IIb mpox patients: interim results of a long-term follow-up study, Belgium, June to November 2022
Nicole Berens-Riha, Stefanie Bracke, Jojanneke Rutgers, et al.
Breast Cancer Research and Treatment
|
September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial
G Viale, F A de Snoo, L Slaets, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
November 20, 2015
Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study
A Kuijer, A C M van Bommel, C A Drukker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 2, 2012
Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy
Annemarie C Schmitz, Kenneth E Pengel, Claudette E Loo, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
Kim M van Pul, Ronald J C L M Vuylsteke, Rieneke van de Ven, et al.
Breast Cancer Research and Treatment
|
December 13, 2017
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 11, 2018
Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer
Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2024
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature
Sena Alaeikhanehshir, Taiwo Ajayi, Frederieke H Duijnhoven, et al.
Page
of 99